mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.09 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |